FMS News and Press, Fresenius Medical Care AG From 10/31/22

Fresenius Medical Care AG & Co. KGaA (FMS) Q3 2022 Earnings Conference Call October 31, 2022 10:30 AM ET Company Participants Dominik Heger - Head of Investor Relations Carla Kriwet - Chief Executive Officer & Chair of the Management Board Helen Giza - De...

Fresenius Medical Care ( NYSE: FMS ) is under pressure to make changes after the company cut its 2022 financial outlook and it was disclosed activist investor Elliott Investment Management now has a 3% stake in the company, Bloomberg reported. The financial new...

The following slide deck was published by Fresenius Medical Care AG & Co. KGaA in conjunction with their 2022 Q3 earnings call. For further details see: Fresenius Medical Care AG & Co. KGaA 2022 Q3 - Results - Earnings Call Presentation

Fresenius Medical Care ( NYSE: FMS ) on Sunday cut its net income outlook for 2022 amid higher labor costs and slower than expected recovery in North America business. The German dialysis care provider's Q3 Basis EPS (excl. special items) declined -16.84% Y...

Summary Fresenius Medical Care has been a long-term laggard in its industry, losing over 70% in the past 5 years. The stock has seemingly bottomed and began to retrace on massive buy-side volume while breaking out of one of its most important short-term resistance. In this tec...

Fresenius Medical Care ( NYSE: FMS ) rose 3.1% in premarket trading on a report that activist Elliott Investment Management took a stake in Fresenius SE & Co. ( OTCPK:FSNUF ). Elliott is said to have taken a substantial position in Fresenius SE and may be looki...

Summary The 2022 bear market has been very painful for stock and bond investors but potentially set us up for an epic rally next year. Individual dividend aristocrats are trading at incredible discounts to historical fair value, close to 60% in some cases. FMS yields a very sa...

Summary Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets remain very volatile following record inflation readings paired with an aggressive Fed and negative consumer sentiment. US inflation is softening in July but continues to...

Summary Shares of tissue regeneration firm Humacyte, Inc. are down over 70% from their opening trade post-SPAC merger in August 2021, dogged by a lack of news and slow trial enrollments. Those dynamics should change as Phase 3 data from its human acellular vessel candidate in the ...

Jefferies downgraded the Fresenius Medical Care ( NYSE: FMS ) ( OTCPK:FSNUF ) ( OTCPK:FSNUY ) to Hold from Buy on Monday as the analysts pointed out that the staffing shortages and inflation could hurt the dialysis provider even after the company reported an improvemen...